RDNT

RadNet, Inc. 10-Q Summary: Period Ended June 30, 2012

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2012, for RadNet, Inc., a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services. As of the reporting date, the company operated 237 centers across seven states, primarily in California, Maryland, Florida, Delaware, New Jersey, Rhode Island, and New York. The company operates as a single segment, providing services including MRI, CT, PET, nuclear medicine, mammography, and ultrasound.

Key Financial Metrics

Note: Total debt includes $200.0 million in senior notes, $278.6 million in term loans, and $59.5 million on the revolving credit facility.

Material Changes vs. Prior Period

• Revenue Growth: Net service fee revenue increased 14.4% year-over-year to $327.4 million. This growth was driven primarily by acquisitions ($47.4 million in revenue from centers acquired since Jan 1, 2011), as organic revenue from existing centers decreased slightly (0.4%) due to lower procedure volumes.
• Profitability: Net income attributable to common stockholders increased 7.2% to $2.8 million. Operating income remained relatively flat at $24.7 million compared to $24.5 million in the prior year.
• Expense Increases: Cost of operations rose 15.8% to $272.0 million, largely due to acquired centers. Interest expense increased 3.8% to $27.0 million due to higher borrowings on the revolving credit facility.
• Cash Flow: Operating cash flow improved significantly, rising 78.5% to $40.8 million, driven by strong collections and adjustments for bad debt provisions.
• Liquidity: Cash and cash equivalents decreased by $2.2 million during the period to $234,000, primarily due to investing activities ($33.4 million used for equipment and acquisitions) and financing activities ($9.6 million used for debt payments).

Guidance, Outlook, and Risks

• Strategy: Management focuses on maximizing performance at existing facilities, profitable contracting, expanding MRI/CT/PET applications, and network expansion through acquisitions.
• Capital Resources: The company operates in a capital-intensive industry. While cash flow from operations and available credit ($61.75 million remaining on the revolving facility) are deemed adequate for short-term needs, the company relies on financing for significant capital expenditures and acquisitions.
• Regulatory Risk: The company faces uncertainty regarding Medicare Physician Fee Schedule payments. While Congress has historically intervened to prevent statutory rate reductions, future failure to act could adversely impact revenues.
• Subsequent Events:
  • July 1, 2012: Sold a 41% interest in a consolidated joint venture for $1.8 million, resulting in de-consolidation.
  • July 23, 2012: Acquired Orthopedic Imaging Center, LLC in Redlands, California, for $700,000.
• Derivatives: The company holds interest rate swaps that are no longer designated as cash flow hedges. Changes in their fair value are recognized in earnings, contributing to "Other income."

Investor Verification Checklist

• Debt Covenants: Verify continued compliance with the New Credit Agreement and senior notes covenants, given the high leverage and equity deficit ($65.0 million).
• Organic Volume Trends: Confirm the sustainability of procedure volumes, as organic revenue from existing centers declined slightly year-over-year.
• Medicare Policy: Monitor Congressional actions regarding the Medicare Physician Fee Schedule conversion factor to assess potential revenue impacts.
• Acquisition Integration: Review the financial performance of recently acquired centers (e.g., West Coast Radiology, Advanced Medical Imaging) to ensure they meet projected returns.
• Bad Debt Provisions: Analyze the trend in the provision for bad debts (3.8% of revenue), which increased alongside revenue, to ensure collection assumptions remain valid.